scispace - formally typeset
A

Ana del Pozo-Rodríguez

Researcher at University of the Basque Country

Publications -  37
Citations -  1447

Ana del Pozo-Rodríguez is an academic researcher from University of the Basque Country. The author has contributed to research in topics: Gene delivery & Transfection. The author has an hindex of 19, co-authored 30 publications receiving 1130 citations.

Papers
More filters
Journal ArticleDOI

Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier

TL;DR: By modifying critical physicochemical parameters of the NLC formulation, this work was able to overcome the P-gp drug efflux and alter the transcytosis mechanism of the nanoparticles, which support the use of NLCs approaches for oral delivery of poorly water-soluble P- gp substrates.
Journal ArticleDOI

Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives

TL;DR: This manuscript includes a revision of the strategies employed to enhance in vitro transcribed mRNA functionality and efficacy, including the optimization of its stability and translational efficiency, as well as the regulation of its immunostimulatory properties.
Journal ArticleDOI

Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway

TL;DR: In spite of the high DNA condensation capacity of protamine and its content in NLS, this does not always lead to an improvement in cell transfection since it may impair some of the limiting steps of the transfections processes.
Journal ArticleDOI

A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases.

TL;DR: The therapeutic plasmid which encodes the protein Retinoschisin was employed achieving a positive transfection in ARPE-19 cells, showing a promising application of this new non-viral system for the treatment of X-linked juvenile retinoschisis by gene therapy.
Journal ArticleDOI

Lipid Nanoparticles as Drug/Gene Delivery Systems to the Retina

TL;DR: Scientific results are summarized that evidence the potential application of lipid nanoparticles as drug delivery systems for the retina and also as nonviral vectors in gene therapy of retina disorders, although much more effort is still needed before these lipidic systems could be available in the market.